Search

Thomas D Aicher

from Ann Arbor, MI
Age ~62
Get Report
Also known as:
Thomas Daniel Aicher, Thomas D Archer, Thomas D Edward, Tom Aicher
Phone and address:
514 Burswood Ct, Ann Arbor, MI 48103
(303) 519-7854
Related to:
Edward D Mclaughlin, 77Orapunn Aicher, 72Joseph Aicher, 32
Connected to:
Dana Aicher, 54Janneke Aicher, 37Lisa A Aicher, 62Margaret L Aicher, 80Matthew W Aicher, 40Robert M Aicher, 85Sheryl J Aicher, 72Ashley L Aichholz, 39Tamsen L Aichinger, 78Esther U Aichner, 74

Thomas Aicher Phones & Addresses

  • 514 Burswood Ct, Ann Arbor, MI 48103 (303) 519-7854
  • Venice, FL
  • Superior, CO
  • Parsippany, NJ
  • 144 Reynolds Ave, Whippany, NJ 07981 (973) 884-2974
  • Cedar Knolls, NJ
  • Morris Plains, NJ
  • Superior, CO
  • 162 Rockwood Ct, Ann Arbor, MI 48103 (303) 519-7854

Work

Position: Precision Production Occupations

Education

Degree: High school graduate or higher

Resumes

Resumes

Thomas Aicher Photo 1

President

View page
Location:
Columbus, OH
Industry:
Higher Education
Work:
Sport & Event Consultants
President
University of Colorado Colorado Springs
Assistant Professor
University of Cincinnati
Associate Professor and Program Coordinator
University of Cincinnati Aug 2011 - Aug 2015
Assistant Professor
Northern Illinois University Aug 2009 - Aug 2011
Assistant Professor
Education:
Texas A&M University Jan 1, 2007 - 2009
Doctorates, Doctor of Philosophy, Sport Management Texas A&M University Jan 1, 2005 - Dec 31, 2007
Master of Science, Masters, Sport Management Virginia Tech - Pamplin College of Business Jan 1, 1995 - 1999
Bachelors, Bachelor of Science, Marketing, Management
Skills:
Sports Management
Sports
Sports Marketing
Public Speaking
Higher Education
Event Management
Event Planning
Teaching
Student Development
Social Networking
Facebook
Student Affairs
Research
Social Media
Powerpoint
Athletics
Marketing
Fundraising
Sponsorship
Public Relations
Thomas Aicher Photo 2

Thomas Aicher

View page
Thomas Aicher Photo 3

Thomas Aicher

View page
Thomas Aicher Photo 4

Thomas Aicher

View page

Publications

Us Patents

Piperazine Substituted Aryl Benzodiazepines

View page
US Patent:
7384934, Jun 10, 2008
Filed:
Jul 28, 2003
Appl. No.:
10/523147
Inventors:
Thomas Daniel Aicher - Superior CO, US
Zhaogen Chen - Noblesville IN, US
Yvan LeHuerou - Boulder CO, US
Fionna Mitchell Martin - Basingstoke, GB
Vincent Patrick Rocco - Indianapolis IN, US
Kevin Michael Ruley - Indianapolis IN, US
John Mehnert Schaus - Zionsville IN, US
Patrick Gianpietro Spinazze - Avon IN, US
David Edward Tupper - Basingstoke, GB
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 403/04
C07D 495/04
C07D 513/04
A61K 31/55
A61P 25/18
US Classification:
514219, 514220, 540555, 540557
Abstract:
Described herein are compounds of formula (I) wherein: is an optionally benzo-fused five or six member aromatic ring having zero to three hetero atoms independently selected from N, S, and O; Alk is (C) alkylene or hydroxy substituted (C) alkylene; X is oxygen or sulfur; Ris hydrogen, (C) fluroalkyl, (C) cycloalkyl, or (C) alkyl, wherein the (C) alkyl is unsubstituted or substituted with hydroxy, methoxy, ethoxy, OCHCHOH, or —CN; Ris H, halogen, (C) fluoroalkyl, (C) cycloalkyl, OR, SR, NO, CN, COR, C(O)OR, CONRR, NRR, SONRR, NRCOR, NRSOR, optionally substituted aromatic, or (C) alkyl, wherein (C) alkyl is unsubstituted or substituted with a hydroxy group; Ris hydrogen (C) fluoroalkyl, (C) alkenyl, Ar, (C)alkyl-Ar, or (C) alkyl wherein (C) alkyly is unsubstituted or substituted with a phenyl; Ris hydrogen, (C) alkyl, (C) fluoroalkyl, or optionally substituted aromatic; Rand Rare independently hydrogen, (C) alkyl, or optionally substituted aromatic, Ris hydrogen, (C) alkyl, (C) fluoroalkyl, or optionally substituted aromatic; Rand Rare independently hydrogen, (C) alkyl, or optionally substituted aromatic; Ar is optionally substituted phenyl, napthyl, monocyclic heteroaromatic or bicyclic heteroaromatic; Zand Zare independently selected from hydrogen, halogen, (C) alkyl, (C) fluoroalkyl, OR, SR, NO, CN, COR, CONRR, NRR, and optionally substituted aromatic; and all salts, solvates, optical and geometric isomers, and crystalline forms thereof. Also, described are the use of the compounds of formula (I) as antagonists of the dopamine D2 receptor and as agents for the treatment of psychosis and bipolar disorders, and pharmaceutical formulations of the compounds of formula (I).

Mitotic Kinesin Inhibitors And Methods Of Use Thereof

View page
US Patent:
7449486, Nov 11, 2008
Filed:
Oct 17, 2005
Appl. No.:
11/252232
Inventors:
Jeremy Hans - Boulder CO, US
Eli M. Wallace - Lyons CO, US
Qian Zhao - Superior CO, US
Joseph P. Lyssikatos - Superior CO, US
Thomas D. Aicher - Superior CO, US
Ellen R Laird - Longmont CO, US
John Robinson - Commerce City CO, US
Shelley Allen - Loveland CO, US
Assignee:
Array BioPharma Inc. - Boulder CO
International Classification:
A61K 31/433
C07D 285/12
US Classification:
514363, 548136
Abstract:
This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.

Potentiators Of Glutamate Receptors

View page
US Patent:
7598423, Oct 6, 2009
Filed:
Nov 15, 2005
Appl. No.:
11/718753
Inventors:
Thomas Daniel Aicher - Superior CO, US
Guillermo S. Cortez - Indianapolis IN, US
Todd Michael Groendyke - Ann Arbor MI, US
Albert Khilevich - Westfield IN, US
James Allen Knobelsdorf - Fishers IN, US
Fredrik Pehr Marmsater - Longmont CO, US
Jeffrey Michael Schkeryantz - Fishers IN, US
Tony Pisal Tang - Longmont CO, US
Nicholas Andrew Magnus - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 239/26
C07D 239/28
C07D 241/10
C07D 401/10
C07D 213/02
C07D 291/04
C07D 271/06
C07D 277/20
C07D 417/10
C07D 333/06
C07D 319/06
C07C 49/76
US Classification:
568331, 549 75, 549 78, 549274, 549495, 549502, 548122, 548132, 548182, 548194, 548206, 548236, 548243, 548247, 548253, 5482632, 5483164, 548544, 5462681, 546340, 544297, 544298, 544335, 544336
Abstract:
This application relates to a substituted hydroxyphenyl ketone compound of formula I, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof and its use in treating migraine.

Potentiators Of Glutamate Receptors

View page
US Patent:
7678794, Mar 16, 2010
Filed:
Nov 15, 2005
Appl. No.:
11/718742
Inventors:
Thomas Daniel Aicher - Superior CO, US
Guillermo S. Cortez - Indianapolis IN, US
Todd Michael Groendyke - Ann Arbor MI, US
Albert Khilevich - Westfield IN, US
James Allen Knobelsdorf - Fishers IN, US
Fredrik Pehr Marmsater - Longmont CO, US
Jeffrey Michael Schkeryantz - Fishers IN, US
Tony Pisal Tang - Longmont CO, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31/50
C07D 209/54
US Classification:
514247, 514381, 548408
Abstract:
The present invention provides a compound of formula (I): pharmaceutical compositions thereof, and methods of using the same, processes for preparing the same, and intermediates thereof.

Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1

View page
US Patent:
7713979, May 11, 2010
Filed:
Oct 26, 2005
Appl. No.:
11/718111
Inventors:
Thomas Daniel Aicher - Superior CO, US
Mark Joseph Chicarelli - Longmont CO, US
Ronald Jay Hinklin - Longmont CO, US
Hongqi Tian - Longmont CO, US
Owen Brendan Wallace - Zionsville IN, US
John Gordon Allen - Newbury Park CA, US
Zhaogen Chen - Shanghai, CN
Thomas Edward Mabry - Indianapolis IN, US
Jefferson Ray McCowan - Indianapolis IN, US
Nancy June Snyder - Lizton IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 207/00
A61K 31/40
A61K 31/497
A61K 31/445
C07D 211/06
C07D 403/00
US Classification:
51425402, 514326, 514424, 544372, 546226, 548543
Abstract:
The present invention discloses compounds of Formula I: (I) having 11beta-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as the use of the Formula I and compositions as medicaments to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, Syndrome X, and other conditions associated with hyperglycemia.

Potentiators Of Glutamate Receptors

View page
US Patent:
7803938, Sep 28, 2010
Filed:
Aug 28, 2009
Appl. No.:
12/549571
Inventors:
Thomas Daniel Aicher - Superior CO, US
Guillermo S. Cortez - Indianapolis IN, US
Todd Micheal Groendyke - Ann Arbor MI, US
Albert Khilevich - Westfield IN, US
James Allen Knobelsdorf - Fishers IN, US
Fredrik Pehr Marmsater - Boulder CO, US
Jeffrey Michael Schkeryantz - Fishers IN, US
Tony Pisal Tang - Longmont CO, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 239/32
C07D 271/113
C07D 291/04
US Classification:
544242, 548122, 548131
Abstract:
This application relates to a substituted hydroxyphenyl ketone compound of formula I, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof and its use in treating migraine. This application also relates to processes for preparing a compound of formula I, and intermediate compounds useful therein.

Potentiators Of Glutamate Receptors

View page
US Patent:
7816523, Oct 19, 2010
Filed:
Aug 28, 2009
Appl. No.:
12/549552
Inventors:
Thomas Daniel Aicher - Superior CO, US
Guillermo S. Cortez - Indianapolis IN, US
Todd Michael Groendyke - Ann Arbor MI, US
Albert Khilevich - Westfield IN, US
James Allen Knobelsdorf - Fishers IN, US
Fredrik Pehr Marmsater - Boulder CO, US
Jeffrey Michael Schkeryantz - Fishers IN, US
Tony Pisal Tang - Longmont CO, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 239/32
C07D 213/02
US Classification:
544242, 5462681, 546340, 546342
Abstract:
This application relates to a substituted hydroxyphenyl ketone compound of formula I, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof and its use in treating migraine.

Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1

View page
US Patent:
7834194, Nov 16, 2010
Filed:
Dec 16, 2005
Appl. No.:
11/722101
Inventors:
Thomas Daniel Aicher - Superior CO, US
Mark Joseph Chicarelli - Longmont CO, US
Ronald Jay Hinklin - Longmont CO, US
Hongqi Tian - Longmont CO, US
Owen Brendan Wallace - Zionsville IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 411/06
A61K 31/4025
US Classification:
548525, 514422
Abstract:
The present invention provides compounds of formula I that are useful as potent and selective inhibitors of 11-beta hydroxysteroid dehydrogenase 1. The present invention further provides a pharmaceutical composition which comprises a compound of Formula I, or a pharmaceutical salt thereof, and a pharmaceutically acceptable carrier, diluent, or excipient. In addition, the present invention provides compositions comprising compounds of formula I for the treatment of metabolic syndrome, diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, other symptoms associated with hyperglycemia, and related disorders. Formula (I) wherein, Ris (II), or (III) Gis methylene or ethylene; L is a divalent linking group selected from —(C-C) alkylene-, —S—, —CH(OH)—, or —O—; A is methylene, —S—, —O—, or —NH—; and the other substituents are as defined in the claims.
Control profile
Thomas D Aicher from Ann Arbor, MI, age ~62 Get Report